Sutro Biopharma STRO
NASDAQ STRO
$16.10 +0.07 (+0.44%)
At close: Sep 29, 2026 · 4:00 PM EDT

Sutro Biopharma (STRO) Non Operating Income (2024 - 2026)

Updated

Sutro Biopharma's Non Operating Income came in at -$8.64 million for Q2 2026, compared with -$8.17 million a year earlier.

Analysis

Sutro Biopharma (STRO) Non Operating Income (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Sutro Biopharma reported Non Operating Income of -$34.01 million; for FY2025, it was -$32.81 million.

  • Going back by year, Non Operating Income was $13.36 million in FY2024, $677,000 in FY2023 (-94.5%) and $12.24 million in FY2022.
  • The five-year range for quarterly Non Operating Income is -$8.8 million (Q4 2025) to $19.13 million (Q3 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 387.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Sutro Biopharma 265.72 Mn -412.78 Mn - -8.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.64 Mn
Dec 31, 2025 -8.80 Mn
Sep 30, 2025 -8.40 Mn
Jun 30, 2025 -8.17 Mn
Mar 31, 2025 -7.45 Mn
Dec 31, 2024 -4.83 Mn
Sep 30, 2024 19.13 Mn
Jun 30, 2024 675,000.00
Mar 31, 2024 -1.62 Mn
API Access

Sutro Biopharma Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=STRO&period=max&api_key=YOUR_API_KEY